脑肿瘤放射增敏剂的实验与临床研究，特别提及5-溴脱氧尿苷-抗代谢物持续区域灌注-放射治疗（BAR疗法）。 - Suppr

Suppr

超能文献

Experimental and clinical studies of radiosensitizers in brain tumors, with special reference to BUdR-antimetabolite continuous regional infusion-radiation therapy (BAR therapy).

作者信息

Sano K, Sato F, Hoshino T, Nagai M

出版信息

Neurol Med Chir (Tokyo). 1965;7:51-72. doi: 10.2176/nmc.7.51.

DOI:10.2176/nmc.7.51

PMID:4162242

Abstract

摘要

相似文献

Experimental and clinical studies of radiosensitizers in brain tumors, with special reference to BUdR-antimetabolite continuous regional infusion-radiation therapy (BAR therapy).脑肿瘤放射增敏剂的实验与临床研究，特别提及5-溴脱氧尿苷-抗代谢物持续区域灌注-放射治疗（BAR疗法）。

Neurol Med Chir (Tokyo). 1965;7:51-72. doi: 10.2176/nmc.7.51.

Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas.恶性胶质瘤的动脉内溴脱氧尿苷放射增敏作用。

Int J Radiat Oncol Biol Phys. 1990 Aug;19(2):421-8. doi: 10.1016/0360-3016(90)90552-u.

Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas.动脉内注射溴脱氧尿苷放射增敏及放疗在恶性星形细胞瘤治疗中的应用

J Neurosurg. 1988 Oct;69(4):500-5. doi: 10.3171/jns.1988.69.4.0500.

A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation.一项关于间歇性静脉注射溴脱氧尿苷（BUdR）与传统分割照射的I期研究。

Int J Radiat Oncol Biol Phys. 1984 Jan;10(1):69-76. doi: 10.1016/0360-3016(84)90414-0.

[Chemotherapy of metastatic brain tumors, with special reference to continuous intracranial infusion of mitomycin C and a radiosensitizer, BUdR].[转移性脑肿瘤的化疗，特别提及丝裂霉素C和放射增敏剂溴脱氧尿苷的持续颅内输注]

Gan No Rinsho. 1971 Apr;17(4):263-8.

Clinical trial of intravenous infusion of bromodeoxyuridine (BUdR) for radiosensitization of malignant brain tumors.静脉输注溴脱氧尿苷（BUdR）用于恶性脑肿瘤放射增敏的临床试验。

Radiat Med. 1988 Jan-Feb;6(1):33-9.

[Treatment of malignant brain tumors by the intrathecal administration of BAR (EUdR-antimetabolite-radiation)].通过鞘内注射BAR（5-溴-2'-脱氧尿苷-抗代谢物-辐射）治疗恶性脑肿瘤

No To Shinkei. 1972 May;24(5):585-93.

The use of halogenated thymidine analogs as clinical radiosensitizers: rationale, current status, and future prospects: non-hypoxic cell sensitizers.卤代胸苷类似物作为临床放射增敏剂的应用：原理、现状及未来前景：非乏氧细胞增敏剂

Int J Radiat Oncol Biol Phys. 1984 Aug;10(8):1399-406. doi: 10.1016/0360-3016(84)90357-2.

Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors.静脉注射溴脱氧尿苷与放射治疗联合用于原发性恶性脑肿瘤患者的I期研究。

Int J Radiat Oncol Biol Phys. 1984 Sep;10(9):1769-72. doi: 10.1016/0360-3016(84)90546-7.

The effects of "BAR" therapy on oral malignant tumors.“BAR”疗法对口腔恶性肿瘤的影响。

J Maxillofac Surg. 1978 May;6(2):98-103. doi: 10.1016/s0301-0503(78)80076-9.

引用本文的文献

[Cellular replacement strategies and adult neurogenesis in idiopathic Parkinson's disease].[特发性帕金森病中的细胞替代策略与成人神经发生]

Nervenarzt. 2016 Aug;87(8):805-13. doi: 10.1007/s00115-016-0157-2.

Experimental studies on potentiation of the antitumor activity of 5-fluorouracil with 3'-azido-3'-deoxythymidine for the gastric cancer cell line MKN28 in vivo.体内对胃癌细胞系MKN28进行5-氟尿嘧啶与3'-叠氮基-3'-脱氧胸苷联合增强抗肿瘤活性的实验研究。

Jpn J Cancer Res. 1997 Jan;88(1):97-102. doi: 10.1111/j.1349-7006.1997.tb00307.x.

[Results of postoperative treatment of glioblastoma multiforme with a radiation-sensitizing substance (5-bromo-2-deoxyuridine)].[多形性胶质母细胞瘤术后使用放射增敏剂（5-溴-2-脱氧尿苷）的治疗结果]

Acta Neurochir (Wien). 1971;24(4):263-8. doi: 10.1007/BF01405412.

Proliferative activity of human tumors: assessment using bromodeoxyuridine and flow cytometry.人类肿瘤的增殖活性：使用溴脱氧尿苷和流式细胞术进行评估。

Jpn J Cancer Res. 1991 Mar;82(3):357-62. doi: 10.1111/j.1349-7006.1991.tb01854.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验